The Journal of Pathology
An abstract of the work presented at the Leeds Pathology Conference (2-4 July, 2019) has now been published in The Journal of Pathology, Volume 249 (Issue S1) Page S56.
International Journal of Cancer
VAL developed four monoclonal antibodies towards novel cancer biomarkers (CIDEA, ELOVL3, ELOVL5 and UCP1). These antibodies were validated and used to characterise the expression of the corresponding targets in colorectal cancer.